Cara Therapeutic Stock Price on June 20, 2023
| CARA Stock | USD 0.26 0.01 3.30% |
Below is the normalized historical share price chart for Cara Therapeutic extending back to January 31, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cara Therapeutic stands at 0.26, as last reported on the 12th of December 2024, with the highest price reaching 0.26 and the lowest price hitting 0.26 during the day.
If you're considering investing in Cara Stock, it is important to understand the factors that can impact its price. At this point, Cara Therapeutic is unstable. Cara Therapeutic secures Sharpe Ratio (or Efficiency) of 0.0348, which signifies that the company had a 0.0348% return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Cara Therapeutic, which you can use to evaluate the volatility of the firm. Please confirm Cara Therapeutic's Mean Deviation of 3.1, downside deviation of 4.94, and Risk Adjusted Performance of 0.0143 to double-check if the risk estimate we provide is consistent with the expected return of 0.15%.
At present, Cara Therapeutic's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 136.4 M, whereas Common Stock Total Equity is forecasted to decline to about 33.2 K. . As of December 12, 2024, Price To Sales Ratio is expected to decline to 1.82. In addition to that, Price Earnings Ratio is expected to decline to -0.36. Cara Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 31st of January 2014 | 200 Day MA 0.4884 | 50 Day MA 0.287 | Beta 0.681 |
Cara |
Sharpe Ratio = 0.0348
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | CARA | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.29 actual daily | 38 62% of assets are more volatile |
Expected Return
| 0.15 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Cara Therapeutic is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cara Therapeutic by adding it to a well-diversified portfolio.
Price Book 20.7163 | Enterprise Value Ebitda (2.32) | Price Sales 1.332 | Shares Float 46.8 M | Wall Street Target Price 1.0067 |
Cara Therapeutic Valuation on June 20, 2023
It is possible to determine the worth of Cara Therapeutic on a given historical date. On June 20, 2023 Cara was worth 3.19 at the beginning of the trading date compared to the closed value of 3.19. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cara Therapeutic stock. Still, in general, we apply an absolute valuation method to find Cara Therapeutic's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cara Therapeutic where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cara Therapeutic's related companies.
| Open | High | Low | Close | Volume | |
| 3.26 | 3.31 | 3.16 | 3.20 | 8,024,578 | |
06/20/2023 | 3.19 | 3.31 | 3.07 | 3.19 | 2,539,269 |
| 3.16 | 3.31 | 3.01 | 3.26 | 1,315,509 |
| Backtest Cara Therapeutic | | | Cara Therapeutic History | | | Cara Therapeutic Valuation | Previous | Next |
Cara Therapeutic Trading Date Momentum on June 20, 2023
| On June 21 2023 Cara Therapeutic was traded for 3.26 at the closing time. The top price for the day was 3.31 and the lowest listed price was 3.01 . The trading volume for the day was 1.3 M. The trading history from June 21, 2023 was a factor to the next trading day price jump. The overall trading delta against the next closing price was 2.19% . The overall trading delta against the current closing price is 10.66% . |
Cara Therapeutic Fundamentals Correlations and Trends
By evaluating Cara Therapeutic's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cara Therapeutic's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cara financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cara Therapeutic Stock history
Cara Therapeutic investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cara is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cara Therapeutic will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cara Therapeutic stock prices may prove useful in developing a viable investing in Cara Therapeutic
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 54.1 M | 35.8 M | |
| Net Loss | -76.9 M | -80.8 M |
Cara Therapeutic Quarterly Net Working Capital |
|
Cara Therapeutic Stock Technical Analysis
Cara Therapeutic technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Cara Therapeutic Period Price Range
Low | December 12, 2024
| High |
0.00 | 0.00 |
Cara Therapeutic cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cara Therapeutic December 12, 2024 Market Strength
Market strength indicators help investors to evaluate how Cara Therapeutic stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cara Therapeutic shares will generate the highest return on investment. By undertsting and applying Cara Therapeutic stock market strength indicators, traders can identify Cara Therapeutic entry and exit signals to maximize returns
Cara Therapeutic Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cara Therapeutic's price direction in advance. Along with the technical and fundamental analysis of Cara Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cara to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0143 | |||
| Jensen Alpha | (0.07) | |||
| Total Risk Alpha | (0.66) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.031 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Cara Stock analysis
When running Cara Therapeutic's price analysis, check to measure Cara Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cara Therapeutic is operating at the current time. Most of Cara Therapeutic's value examination focuses on studying past and present price action to predict the probability of Cara Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cara Therapeutic's price. Additionally, you may evaluate how the addition of Cara Therapeutic to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |